Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-153640
Filing Date
2018-05-07
Accepted
2018-05-07 08:30:56
Documents
10
Period of Report
2018-06-20
Effectiveness Date
2018-05-07

Document Format Files

Seq Description Document Type Size
1 DEF 14A d572271ddef14a.htm DEF 14A 488505
2 GRAPHIC g572271g15t58.jpg GRAPHIC 1701
3 GRAPHIC g572271g18u22.jpg GRAPHIC 43967
4 GRAPHIC g572271g35y65.jpg GRAPHIC 14396
5 GRAPHIC g572271g37o39.jpg GRAPHIC 3398
6 GRAPHIC g572271g54o89.jpg GRAPHIC 18467
7 GRAPHIC g572271g54r58.jpg GRAPHIC 1960
8 GRAPHIC g572271g79q73.jpg GRAPHIC 5578
9 GRAPHIC g572271g85s97.jpg GRAPHIC 2144
10 GRAPHIC g572271g99u93.jpg GRAPHIC 165642
  Complete submission text file 0001193125-18-153640.txt   844614
Mailing Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080 650-635-7000
MATEON THERAPEUTICS INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-21990 | Film No.: 18809760
SIC: 2836 Biological Products, (No Diagnostic Substances)